Issue 24

A Future Beyond Biopharma Incubators: Could CDMOs Redefine Startups?

Why not sign up for our future email newsletters? Sign up here.

In this issue:

LEAD STORY

Could CDMOs Replace the Need for Biopharma Incubators?

If you were to launch a biopharma startup today, where would you find the skills, talent, and space to bring your vision to life? Biopharma incubators are usually the answer.  

Read more here.

FEATURED STORIES

Aptar Recognized Among Forbes’ Top 50 Companies for Women in 2024

Read more here.

EU Regulators Scrutinize Novo Holdings' Catalent Acquisition  

Read more here.

SCHOTT Pharma Expands Glass Syringe Production with New Hungary Facility 

Read more here.

Thermo Fisher Restructures Viral Vector Operations with 160 Layoffs

Read more here.

Novo Nordisk to Halt Human Insulin Pen Production

Read more here.

Lonza Expands Swiss Bioconjugation Facilities to Meet Rising Demand

Read more here.

Accord Healthcare Secures Investment to Boost Medicine Manufacturing in the UK

Read more here.

Sekisui Diagnostics Expands cGMP Biopharma CDMO Capacity  

Read more here.

Otsuka and ICU Medical Partner to Enhance North American IV Solutions Supply 

Read more here.

RFK in the Cabinet: A Reformist Vision or Threat to Scientific Integrity?

Read more here.

Eurofins CDMO Alphora Inc. to Build Advanced GMP Biologics Manufacturing Facility  

Read more here.

Private Equity Firms Acquire Biologics CDMO Avid Bioservices

Read more here.

Ascend Advanced Therapies Partners with EW Healthcare to Boost U.S. Gene Therapy Manufacturing Capacity  

Read more here.

AstraZeneca Commits USD 3.5 Billion to U.S. Biopharmaceutical Expansion

Read more here.

Metsera Secures USD 215 Million to Advance Obesity Treatments and GLP-1 Drug Development  

Read more here.

BioNTech to Acquire Biotheus to Strengthen Oncology Pipeline   

Read more here.

GSK and Vesalius Therapeutics Partner to Advance Parkinson's Research

Read more here.